EP3755369 - ONCOLYTIC VIRUSES AS ADJUVANTS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 27.11.2020 Database last updated on 02.11.2024 | |
Former | The international publication has been made Status updated on 31.08.2019 | Most recent event Tooltip | 07.05.2024 | Change - representative | Applicant(s) | For all designated states Turnstone Limited Partnership Turnstone (GP) Ontario Inc. c/o Osler Hoskin & Harcourt LLP, 100 King Street West 1 First Canadian Place, Suite 6200 P.O. Box 50 Toronto ON M5X 1B8 / CA | [2021/01] | Inventor(s) | 01 /
BOURGEOIS-DAIGNEAULT, Marie-Claude 1541 rue Notre-Dame-de-Grâces Longueuil Québec J4J 3G3 / CA | 02 /
BELL, John 248 Knox Crescent Ottawa, Ontario K1G 0K8 / CA | [2021/01] | Representative(s) | ABG Intellectual Property Law, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | [N/P] |
Former [2021/01] | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | Application number, filing date | 19756747.2 | 22.02.2019 | [2021/01] | WO2019CA50220 | Priority number, date | US201862633883P | 22.02.2018 Original published format: US 201862633883 P | US201862751091P | 26.10.2018 Original published format: US 201862751091 P | [2021/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019161505 | Date: | 29.08.2019 | Language: | EN | [2019/35] | Type: | A1 Application with search report | No.: | EP3755369 | Date: | 30.12.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.08.2019 takes the place of the publication of the European patent application. | [2020/53] | Search report(s) | International search report - published on: | CA | 29.08.2019 | (Supplementary) European search report - dispatched on: | EP | 21.12.2021 | Classification | IPC: | C07K14/47, A61K39/39, A61K35/76, A61K35/761, A61K35/766, A61K35/68, A61K35/768, A61K39/00, A61P37/04, A61P35/00 | [2022/03] | CPC: |
A61P35/00 (EP);
A61K39/39 (EP,US);
A61K35/761 (US);
A61K35/766 (US);
A61K35/768 (EP,US);
A61K39/0011 (EP,US);
A61P37/04 (EP,US);
A61K2039/5252 (EP,US);
A61K2039/54 (EP,US);
A61K2039/545 (EP,US);
A61K2039/572 (EP);
A61K2039/585 (EP);
C07K14/4748 (EP);
C12N2710/10334 (EP);
C12N2710/10343 (EP);
C12N2760/20034 (EP);
C12N2760/20043 (EP);
C12N2760/20234 (EP);
C12N2760/20243 (EP)
(-)
|
Former IPC [2021/01] | A61K39/39, A61K35/76, A61K35/761, A61K35/766, A61K35/68, A61K35/768, A61K39/00, A61P37/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/01] | Title | German: | ONKOLYTISCHE VIREN ALS ADJUVANTIEN | [2021/01] | English: | ONCOLYTIC VIRUSES AS ADJUVANTS | [2021/01] | French: | VIRUS ONCOLYTIQUES EN TANT QU'ADJUVANTS | [2021/01] | Entry into regional phase | 21.09.2020 | National basic fee paid | 21.09.2020 | Search fee paid | 21.09.2020 | Designation fee(s) paid | 21.09.2020 | Examination fee paid | Examination procedure | 21.09.2020 | Examination requested [2020/53] | 21.07.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 11.01.2021 | Renewal fee patent year 03 | 20.12.2021 | Renewal fee patent year 04 | 12.12.2022 | Renewal fee patent year 05 | 12.02.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2014127478 (CHILDREN S HOSPITAL OF EASTERN ONTARIO RES INST INC [CA], et al); | [A]WO2015177098 (HELSINGIN YLIOPISTO [FI]); | [A]WO2016025295 (UNIV JOHNS HOPKINS [US]); | [Y]WO2017195032 (LICHTY BRIAN [CA]); |